Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.63M | -19.81M | -23.98M | -43.04M | -62.11M |
| Total Depreciation and Amortization | 660.00K | 674.50K | 689.00K | 704.50K | 720.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.85M | 5.85M | 4.86M | 4.33M | 3.79M |
| Change in Net Operating Assets | -15.49M | -10.81M | -6.12M | 1.86M | 9.85M |
| Cash from Operations | -23.61M | -24.09M | -24.56M | -36.15M | -47.74M |
| Capital Expenditure | -750.00K | -489.00K | -228.00K | -154.50K | -81.00K |
| Sale of Property, Plant, and Equipment | -- | 1.00K | 2.00K | 2.00K | 2.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.70M | 25.35M | 53.40M | 64.23M | 75.06M |
| Cash from Investing | -3.45M | 24.86M | 53.17M | 64.07M | 74.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -2.00K | -4.00K | -2.00K | 0.00 |
| Issuance of Common Stock | 227.00K | 176.00K | 125.00K | 85.00K | 45.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 227.00K | 174.00K | 121.00K | 83.00K | 45.00K |
| Foreign Exchange rate Adjustments | -595.00K | -520.50K | -446.00K | -507.00K | -568.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.43M | 426.50K | 28.28M | 27.50M | 26.72M |